跳至主要内容
临床试验/IRCT20161103030680N9
IRCT20161103030680N9已完成2 期

Evaluation of citalopram efficacy in prevention of migraine headaches

Shahed University0 个研究点目标入组 226 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
226

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Age between 18 to 45.
  • Suffering from migraine headaches according to international headache society criteria(IHS).
  • At least three attack of migraine in one month.
  • History of migraine for at least six months.

排除标准

  • Suffering from another type of headaches such as Cluster,Tension,.... .
  • History of Asthma, Renal and Heart failure, Depression, any allergic reaction to drugs used in study or similar drugs.
  • Patients who already take drugs for treatment for migraine.
  • History of using anti depressant, anti epileptics, Analgesics, Corticosteroids, Opium, Monoamine Oxidase, and Non steroidal anti inflammatory agents for other reasons.

研究者

相似试验